secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001193125-26-068813
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Decoy Therapeutics shareholders approve 2026 equity plan and reverse stock split
--------------------------------------------------------------------------------

- Approved 2026 Equity Incentive Plan: 351,837 for, 68,978 against, 55,703 abstentions.
- Approved reverse stock split of common stock at ratio between 1:4 and 1:15, at board's discretion.
- Reverse split proposal: 2,187,125 votes for, 507,474 against, 2,173 abstentions.
- Adjournment proposal was unnecessary due to sufficient votes; broker non-votes totaled 2,220,254.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000119312526068813/0001193125-26-068813-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000119312526068813/dcoy-20260224.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-068813

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer